Skip to content
MarketScale
‹ Back to IndustriesSciences

SupplySide West 2021: Market Trends

SupplySide West 2021 serves as a critical platform for companies like Deerland to innovate and stay attuned to market trends. The event enables face-to-face interactions, allowing Deerland to engage directly with customers and industry peers. Deerland aims to expand beyond supplements into food and beverage sectors, leveraging versatile ingredient applications and exploring diverse product formats.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Diverse Delivery FormatsFood and BeverageHuman-grade IngredientsIndustry Trends.
Share
SupplySide West 2021: Market Trends

Key takeaways

01

SupplySide West provides a platform for innovation and understanding customer needs.

02

Deerland is expanding into food and beverage through versatile ingredient applications.

03

Embracing diverse delivery formats, like gummies and liquids, attracts significant interest.

Get featured

Want MarketScale to feature Sciences?

Book a 15-minute demo and we'll map your Sciences expertise to the content buyers are searching for.

Book a demo

Supply Side West holds immense significance for Deerland, providing a platform for innovation and a chance to understand customer needs. This event keeps Deerland in tune with market trends and ensures the development of impactful and sought-after products. The return to in-person interactions at Supply Side West is truly invigorating, allowing Deerland to engage with industry peers and customers face-to-face.

With a focus on food and beverage, Deerland aims to expand its reach beyond the supplement space. The goal is to showcase the versatility of their ingredients, probiotics, and Solarplast in diverse applications. Embracing different delivery formats is a key trend, with gummies and liquid formats gaining significant interest. By exploring new avenues outside traditional capsules, Deerland aims to meet evolving consumer preferences and offer innovative solutions.

The connection between the human and pet industries is becoming increasingly apparent. Consumers seek clean and functional ingredients that enhance the health and well-being of both themselves and their pets. Deerland already produces human-grade ingredients, aligning with the growing demand for quality in the pet industry. As the pet market evolves, new ingredients will play a crucial role. Combining probiotics with prebiotics or phages to create synergistic functional ingredients holds promise for future pet products.

Supply Side West’s incorporation of food ingredients is a welcome development, as it highlights the blending of the food and supplement sectors. Deerland has identified complementary ingredients that can enhance their flagship DE111 probiotic, such as powdered kombucha, powdered kefir, and the growing interest in hemp and botanicals. The opportunities are endless, and Supply Side West offers a diverse and vibrant environment to explore and learn from.

Attending Supply Side West for the first time has provided a fresh perspective for Deerland. Stepping out of their comfort zone and witnessing the broader industry landscape has been both insightful and enjoyable. It’s not only about understanding industry trends but also recognizing the impact that DE111, Deerland’s flagship product, is making in the market.

Deerland remains committed to staying at the forefront of innovation and responding to customer demands. By embracing new ingredients, exploring novel delivery formats, and maintaining a human-grade standard, Deerland aims to drive positive change and contribute to the well-being of people and pets alike.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Sony and TSMC's $6.3 billion image-sensor bet signals a new era of chip co-investment

Sony and TSMC's $6.3 billion image-sensor bet signals a new era of chip co-investment

Sony and TSMC have announced a joint investment of $6.3 billion to develop next-generation image-sensor chips. This collaboration is driven by the increasing demand for AI technologies, which is influencing changes in semiconductor supply chains. The initiative is expected to have significant impacts in 2026.

  • 01Sony and TSMC are investing $6.3 billion in next-generation image-sensor chips.
  • 02The investment is motivated by rising demand for AI technologies.
  • 03The partnership is a notable example of co-investment in the semiconductor industry.

Aug 12, 2026

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512